Portland, OR, May 11, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global Ophthalmic Drugs Market was accounted for $36.48 billion in 2019, and is estimated to reach $58.13 billion by 2027, growing at a CAGR of 5.6% from 2020 to 2027.
Rise in prevalence of ophthalmic disorders, growth in geriatric population, surge in demand for ophthalmic drugs, and advancements in R&D in optometry drive the growth of the global ophthalmic drugs market. However, risks associated with ophthalmic drugs and longer timeline required for the formulation of ophthalmic drugs hinder the market growth. On the contrary, surge in R&D activities by major players is expected to open lucrative opportunities in the future.
Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/310
Covid-19 scenario:
- The Covid-19 pandemic and followed by lockdown has affected several drug manufacturing companies.
- The prolonged lockdown resulted in a disrupted supply chain and increased the prices of raw materials.
- However, as the world has been recovering from the pandemic, the market is estimated to get back on track.
The global ophthalmic drugs market is segmented on the basis of indication, type, dosage form, distribution channel, therapeutic class, and region. Based on indication, the retinal disorders segment held the largest share in 2019, accounting for more than one-fourth of the market. However, the glaucoma segment is estimated to manifest the highest CAGR of 6.2% during the forecast period.
On the basis of type, the prescription drugs segment dominated the market in 2019, contributing to more than three-fourths of the market. However, the over-the-counter drugs segment is projected to manifest the highest CAGR of 6.7% during the forecast period.
Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/310
The global ophthalmic drugs market is analyzed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America held the lion’s share in 2019, contributing to more than one-third of the market. However, the market across Asia-Pacific is estimated to portray the highest CAGR of 7.1% during the forecast period.
The global ophthalmic drugs market includes an in-depth analysis of the prime market players such as Alcon Inc., AbbVie Inc. (Allergen plc.), F. Hoffmann-La Roche Ltd (Genentech, Inc.), Bausch & Lomb Incorporated, Pfizer Inc., Novartis AG, Santen Pharmaceutical Co. Ltd., Regeneron Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd. (Actavis Generics), and Sun Pharmaceutical Industries Ltd.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.
Similar Reports:
Ophthalmic Devices Market - Global Opportunity Analysis and Industry Forecast, 2020–2027
Ophthalmic Knives Market - Global Opportunity Analysis and Industry Forecast, 2019-2027
Eye Care Surgical Market - Global Opportunity Analysis and Industry Forecast, 2019–2027
End Stage Renal Disease Market - Global Opportunity Analysis and Industry Forecast, 2019–2027
Renal Denervation Market - Global Opportunity Analysis and Industry Forecast, 2019–2027
Renal Biomarkers Market - Global Opportunity Analysis and Industry Forecast, 2019–2027
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.